Find the latest FUTURA MEDICAL PLC ORD 0.2P (FUM. L ) stock discussion in Yahoo Finance’s forum. Share your opinion and gain insight from other stock traders and investors.
Futura Medical Share Chat. Chat About FUM Shares – Stock Quote, Charts, Trade History, Share Chat, Financial Terms Glossary.
0.0 Earnings and Valuation. Price to Earnings Ratio vs. the Market. The P/E ratio of Futura Medical is -20.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
17/12/2019 15:23: Yea the Liberum 60p price was after the results. The market got wrong that the eventual marketplace will be substantially greater going down the medical device route.
7/6/2020 · Futura Medical (FUM) share price, charts, trades & the UK’s most popular discussion forums. Free forex prices, toplists, indices and lots more. 16/04/2021 01:42:18 Cookie Policy +44 (0) 203 8794 460 Free Membership Login, Futura Medical Plc Ord 0.2P is listed on the London Stock Exchange, trading with ticker code FUM. It has a market capitalisation of £127m, with approximately 248m shares in issue. Over the last …
Find the latest FUTURA MEDICAL (FAMDF) stock discussion in Yahoo Finance’s forum. Share your opinion and gain insight from other stock traders and investors.
1/17/2015 · Project CARS General Discussion Thread. Discussion in ‘Project CARS 1’ started by Terronium-12, Aug 9, 2012. … * GT Pitcrew: FUM_ L source files, removed obsolete, updated catabe export setup. * F1 Pitcrew: Wheel mechanics and attendants ( LRW, LFW, RRW, RFW) , new exports with faster transitions …
4/16/2020 · At last, some biomarkers, such as Pyr, Cit, OXA, FUM, l -tryptophan, l-threonine, l-leucine, serotonin, and 4-guanidinobutyric acid, correlated with the stability of culture system of C. cohnii M-1-2 were identified. The study proved that repeated fed-batch cultivation was an efficient and energy-saving strategy for industrial production of DHA …
7/14/2020 · MED3000 set to be an OTC product Productive discussions with the FDA have confirmed MED3000 will likely be approvable immediately as an OTC (over-the-counter) medical device, without the need for a prescription-only phase. Importantly, the FDA is comfortable with the quality of the data generated to date and will require only a small six-month clinical study to confirm the efficacy seen in …
